Related Experiment Video
Updated: Nov 28, 2025

Study of Experimental Organ Donation Models for Lung Transplantation
Published on: March 15, 2024
Challenges in Brain Death Determination and Apnea Testing for Patients with COVID-19
Yazan Radaideh1, Rajeev Garg1, Amina A Abdalla2
1Department of Neurological Sciences, Section of Neurocritical Care, Rush University Medical Center, Chicago, IL, United States.
Introduction:
Apnea testing remains essential for the clinical evaluation of brain death determination. In patients who test positive for SARS-CoV-2, disconnecting the patient from the ventilator and introducing high flow oxygen into the endotracheal tube increases the risk for aerosolization of airway secretions and exposure of the examiner.
Methods:
Case report of a patient with an intracerebral hemorrhage that evolved to significant cerebral edema and herniation, who underwent apnea test using a method involving a t-piece and an HME filter.
Results:
Patient successfully pronounced brain dead using a safe method to minimize exposure to SARS-CoV-2.
Conclusion:
At a time where healthcare workers are at high risk of exposure to COVID-19, the above described method is a safe process for apnea testing in declaration of brain death.
Related Concept Videos
Acute Respiratory Failure-IV
Cardiopulmonary Resuscitation II: ACLS Airway Management
Physical Assessment of the Respiratory Tract II: Inspection
Chest Configuration
The chest configuration...
Sleep Apnea
The condition is more prevalent among...
Assessment of Airway, Skin Color, and Use of Accessory Muscles
Introduction
The initial evaluation of a patient's respiratory system...
Respiratory Volumes and Capacities I

